1. Home
  2. TLYS vs VERU Comparison

TLYS vs VERU Comparison

Compare TLYS & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tilly's Inc.

TLYS

Tilly's Inc.

HOLD

Current Price

$4.23

Market Cap

43.3M

ML Signal

HOLD

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.21

Market Cap

40.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLYS
VERU
Founded
1982
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.3M
40.9M
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
TLYS
VERU
Price
$4.23
$2.21
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$2.00
$22.50
AVG Volume (30 Days)
228.6K
54.9K
Earning Date
06-03-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
62.34
N/A
EPS
N/A
N/A
Revenue
N/A
$16,296,958.00
Revenue This Year
$4.66
N/A
Revenue Next Year
$1.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$0.36
52 Week High
$5.54
$4.59

Technical Indicators

Market Signals
Indicator
TLYS
VERU
Relative Strength Index (RSI) 50.83 46.04
Support Level $3.62 $2.12
Resistance Level $4.59 $2.67
Average True Range (ATR) 0.30 0.11
MACD -0.01 -0.00
Stochastic Oscillator 56.68 50.00

Price Performance

Historical Comparison
TLYS
VERU

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Share on Social Networks: